You are here

Eli Lilly

Lilly's tirzepatide aces 2 more late-phase diabetes trials

Fierce Biotech

Wed, 02/17/21 - 11:01 am

type 2 diabetes

clinical trials

Ousted Eli Lilly CFO Loses $24 Million in Potential Pay

BioSpace

Sat, 02/13/21 - 10:56 pm

Eli Lilly scores FDA nod for COVID-19 antibody cocktail, aims to make 1M doses by midyear

Fierce Pharma

Wed, 02/10/21 - 10:16 am

Emergency Use Authorization

Eli Lilly's chief financial officer resigned after a misconduct investigation revealed he sent 'consensual though inappropriate' personal messages to employees

Business Insider

Tue, 02/9/21 - 12:44 pm

inappropriate conduct

Lilly cancer R&D chief Bilenker quits, handing reins to deputy

Fierce Biotech

Tue, 02/2/21 - 11:09 pm

Eli Lilly stock dipped Friday despite reporting better-than-expected fourth-quarter estimates on strong sales of diabetes and cancer drugs

Investors Business Daily

Sat, 01/30/21 - 11:41 pm

Lilly lands clinical-phase pain drug via deal with Asahi Kasei

Fierce Biotech

Thu, 01/28/21 - 10:51 am

neuroinflammatory pain

Lilly amps Type 1 diabetes partnerships to reach more young people

Fierce Pharma

Thu, 01/28/21 - 10:40 am

pharma marketing

type 1 diabetes

Regeneron COVID-19 drug cocktail combats South Africa variant, Lilly's does not - study

Reuters

Wed, 01/27/21 - 08:06 pm

Vir and GSK Team Up with Eli Lilly for Double Monoclonal Antibody Study

BioSpace

Wed, 01/27/21 - 11:32 am

Vir Biotechnology

Lilly antibody combo slashed COVID-19 deaths, hospitalizations in high-risk patients

Fierce Pharma

Tue, 01/26/21 - 11:29 am

3 Blockbuster Drug Launches to Watch This Year

Motley Fool

Sun, 01/24/21 - 03:24 pm

Gilead Sciences

Eli Lilly says its monoclonal antibody prevented Covid-19 infections in clinical trial

Stat

Thu, 01/21/21 - 10:50 am

monoclonal antibodies

clincial trials

AstraZeneca, Sanofi, Eli Lilly sue HHS over 340B opinion

Beckers Hospital Review

Wed, 01/20/21 - 10:42 am

Eli Lilly tees up discovery pact worth more than $1.6B with Merus for T cell-focused bispecific antibodies

Endpoints

Tue, 01/19/21 - 10:39 am

Eli Lilly re-ups diversity pledge, pitching in $30M to venture fund for minority-owned healthcare firms

Endpoints

Sat, 01/16/21 - 11:46 pm

venture capital

Could Lilly’s donanemab readout in Alzheimer’s boost Biogen’s prospects?

Pharmaforum

Thu, 01/14/21 - 10:52 am

Alzheimer's disease

clinical trials

A much-hyped CV drug failed, repeatedly. Now, investors are betting nearly $200M on one last PhIII bid

Endpoints

Thu, 01/14/21 - 10:45 am

cardiovascular disease

NewAmsterdam Pharma

CETP inhibitors

Boehringer, Lilly’s Jardiance ties to match AZ’s Farxiga with heart failure label

Pharmaforum

Tue, 01/12/21 - 10:50 am

Boehringer Ingelheim

Lilly rockets up on mixed Alzheimer's results

BioPharma Dive

Mon, 01/11/21 - 06:53 pm

Alzheimer's disease

clinical trials

Pages